SEK 11.2
(1.36%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 103.5 Million SEK | 27.62% |
2022 | 81.1 Million SEK | 2791.27% |
2021 | 2.8 Million SEK | -80.84% |
2020 | 14.63 Million SEK | 260.63% |
2019 | 4.05 Million SEK | 479.35% |
2018 | -1.07 Million SEK | 81.59% |
2017 | -5.81 Million SEK | -1662.63% |
2016 | 372 Thousand SEK | 103.35% |
2015 | -11.09 Million SEK | -133.1% |
2014 | -4.76 Million SEK | -4.27% |
2013 | -4.56 Million SEK | -27.01% |
2012 | -3.59 Million SEK | -1207.27% |
2011 | -275 Thousand SEK | 94.24% |
2010 | -4.77 Million SEK | 0.0% |
2009 | - SEK | 100.0% |
2008 | -971 Thousand SEK | -188.19% |
2007 | 1.1 Million SEK | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 42.9 Million SEK | 43.48% |
2024 Q2 | 29.8 Million SEK | -30.54% |
2024 Q3 | 11.8 Million SEK | -60.4% |
2023 Q2 | 3.2 Million SEK | -91.01% |
2023 Q3 | 34.8 Million SEK | 987.5% |
2023 FY | 103.5 Million SEK | 27.62% |
2023 Q4 | 29.9 Million SEK | -14.08% |
2023 Q1 | 35.6 Million SEK | 26.79% |
2022 FY | 81.1 Million SEK | 2791.27% |
2022 Q1 | 70 Thousand SEK | -96.06% |
2022 Q2 | 19.05 Million SEK | 27114.29% |
2022 Q3 | 33.9 Million SEK | 77.96% |
2022 Q4 | 28.07 Million SEK | -17.18% |
2021 FY | 2.8 Million SEK | -80.84% |
2021 Q1 | 2.51 Million SEK | -58.31% |
2021 Q2 | 76 Thousand SEK | -96.98% |
2021 Q3 | -1.56 Million SEK | -2157.89% |
2021 Q4 | 1.77 Million SEK | 213.68% |
2020 FY | 14.63 Million SEK | 260.63% |
2020 Q2 | 8.25 Million SEK | 433.85% |
2020 Q1 | -2.47 Million SEK | -129.97% |
2020 Q4 | 6.03 Million SEK | 113.93% |
2020 Q3 | 2.82 Million SEK | -65.83% |
2019 Q3 | -2.52 Million SEK | -47.03% |
2019 FY | 4.05 Million SEK | 479.35% |
2019 Q1 | 46 Thousand SEK | -98.79% |
2019 Q2 | -1.71 Million SEK | -3830.43% |
2019 Q4 | 8.25 Million SEK | 427.07% |
2018 Q2 | -909 Thousand SEK | -991.18% |
2018 Q4 | 3.79 Million SEK | 193.49% |
2018 FY | -1.07 Million SEK | 81.59% |
2018 Q1 | 102 Thousand SEK | 104.18% |
2018 Q3 | -4.05 Million SEK | -346.09% |
2017 Q2 | 962 Thousand SEK | 260.07% |
2017 FY | -5.81 Million SEK | -1662.63% |
2017 Q4 | -2.44 Million SEK | 34.57% |
2017 Q3 | -3.73 Million SEK | -487.94% |
2017 Q1 | -601 Thousand SEK | -511.64% |
2016 FY | 372 Thousand SEK | 103.35% |
2016 Q3 | 951 Thousand SEK | -81.11% |
2016 Q4 | 146 Thousand SEK | -84.65% |
2016 Q2 | 5.03 Million SEK | 187.41% |
2016 Q1 | -5.76 Million SEK | 12.61% |
2015 FY | -11.09 Million SEK | -133.1% |
2015 Q1 | 1.52 Million SEK | 149.11% |
2015 Q2 | -560 Thousand SEK | -136.75% |
2015 Q3 | -5.47 Million SEK | -876.96% |
2015 Q4 | -6.59 Million SEK | -20.47% |
2014 Q4 | -3.1 Million SEK | -41.95% |
2014 Q1 | 413 Thousand SEK | 119.87% |
2014 Q2 | 114 Thousand SEK | -72.4% |
2014 Q3 | -2.18 Million SEK | -2017.54% |
2014 FY | -4.76 Million SEK | -4.27% |
2013 Q4 | -2.07 Million SEK | -160.73% |
2013 FY | -4.56 Million SEK | -27.01% |
2013 Q1 | -1.91 Million SEK | -3976.6% |
2013 Q2 | 225 Thousand SEK | 111.74% |
2013 Q3 | -797 Thousand SEK | -454.22% |
2012 Q3 | -2.05 Million SEK | -1973.74% |
2012 Q1 | -1.39 Million SEK | -280.6% |
2012 Q2 | -99 Thousand SEK | 92.91% |
2012 Q4 | -47 Thousand SEK | 97.71% |
2012 FY | -3.59 Million SEK | -1207.27% |
2011 FY | -275 Thousand SEK | 94.24% |
2011 Q3 | -187 Thousand SEK | -144.1% |
2011 Q4 | 773 Thousand SEK | 513.37% |
2011 Q1 | -1.28 Million SEK | -227.81% |
2011 Q2 | 424 Thousand SEK | 133.0% |
2010 FY | -4.77 Million SEK | 0.0% |
2010 Q4 | -392 Thousand SEK | 78.44% |
2010 Q3 | -1.81 Million SEK | -55.78% |
2010 Q2 | -1.16 Million SEK | 16.28% |
2010 Q1 | -1.39 Million SEK | 0.0% |
2009 Q4 | - SEK | 0.0% |
2009 FY | - SEK | 100.0% |
2009 Q2 | 178 Thousand SEK | 120.3% |
2009 Q1 | -877 Thousand SEK | -98.87% |
2009 Q3 | - SEK | -100.0% |
2008 FY | -971 Thousand SEK | -188.19% |
2008 Q1 | 309 Thousand SEK | -17.6% |
2008 Q2 | 13 Thousand SEK | -95.79% |
2008 Q4 | -441 Thousand SEK | 0.0% |
2007 Q4 | 375 Thousand SEK | 0.0% |
2007 FY | 1.1 Million SEK | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Acarix AB (publ) | -77.83 Million SEK | 232.967% |
ADDvise Group AB (publ) | 103.5 Million SEK | 0.0% |
Arcoma AB | 2.56 Million SEK | -3936.661% |
Bactiguard Holding AB (publ) | -138.38 Million SEK | 174.793% |
BICO Group AB (publ) | -835.7 Million SEK | 112.385% |
Boule Diagnostics AB (publ) | 24.97 Million SEK | -314.381% |
CellaVision AB (publ) | 130.3 Million SEK | 20.573% |
Clinical Laserthermia Systems AB (publ) | -79.79 Million SEK | 229.712% |
Chordate Medical Holding AB (publ) | -29.18 Million SEK | 454.614% |
C-Rad AB (publ) | 35.52 Million SEK | -191.311% |
Duearity AB (publ) | -26.19 Million SEK | 495.189% |
Dignitana AB (publ) | -17.36 Million SEK | 696.095% |
Episurf Medical AB (publ) | -94.8 Million SEK | 209.177% |
Getinge AB (publ) | 2.41 Billion SEK | 95.709% |
Scandinavian Real Heart AB (Publ) | -67.97 Million SEK | 252.257% |
Iconovo AB (publ) | -45.89 Million SEK | 325.521% |
Integrum AB (publ) | 4.03 Million SEK | -2466.66% |
Luxbright AB (publ) | -25.37 Million SEK | 507.88% |
Mentice AB (publ) | -2.81 Million SEK | 3774.121% |
OssDsign AB (publ) | -130.49 Million SEK | 179.315% |
Paxman AB (publ) | 8.33 Million SEK | -1142.497% |
Promimic AB (publ) | -9.22 Million SEK | 1222.316% |
Qlife Holding AB (publ) | -159.95 Million SEK | 164.705% |
SciBase Holding AB (publ) | -55.58 Million SEK | 286.201% |
ScandiDos AB (publ) | -14.64 Million SEK | 806.629% |
Sectra AB (publ) | 428.38 Million SEK | 75.84% |
Sedana Medical AB (publ) | -59.61 Million SEK | 273.623% |
Senzime AB (publ) | -134.14 Million SEK | 177.153% |
SpectraCure AB (publ) | -20.44 Million SEK | 606.335% |
Stille AB | 26.64 Million SEK | -288.426% |
Vitrolife AB (publ) | -3.85 Billion SEK | 102.688% |
Xvivo Perfusion AB (publ) | 91.82 Million SEK | -12.721% |